The Trump Administration's new ‘remain in Mexico’ policy is causing an influx of migrants waiting on the Mexican side of the border. By the time they reach the border, many migrants are traumatized, have untreated chronic diseases and are in need of medical treatment. In response to this dynamic situation, The Harvard Global Health Institute, […]

A discussion on "Plasticity of Human Cells, Synthetic Human Biology, and Beyond" with Dr. George Church, HMS Dept. of Genetics. Register here.

Interested in learning about the budding field of cannabis law? Meet OCS Alumna-in-Residence, Lauren Estevez ’13, Principal & Attorney at LME Law in Los Angeles. Ms. Estevez advises licensed cannabis and CBD brands, investors, and operators on legal strategy, regulatory compliance, and transactional matters. She is a nationally recognized subject matter expert in this field, and […]

The FDA recently approved Keytruda and Vitrakvi, two cancer drugs targeting biomarkers without reference to the site of the disease. Defining cancer in terms of biomarkers alone may require us to rethink the design of clinical trials and raises challenges for the traditional FDA approval process. What is the future of these so-called "tumor-agnostic" therapies, […]

Join us for a panel discussion moderated by Jen Rice, Director of Business Development at Harvard Office of Technology Development (OTD), to learn about resources, advisors, and funding sources available to scientist-entrepreneurs at Harvard. Register here.

Please join the HLS Mississippi Delta Project for our annual Delta Celebration. We’ll be joined by Dr. Kecia Johnson, Assistant Professor at Mississippi State University and Co-Director of the Mississippi Food Insecurity Project. Dr. Johnson’s presentation will provide a conceptual framework for understanding how individuals with a felony drug conviction may be at a greater risk of being food […]